Is It Too Late to Buy Eli Lilly Stock?
Eli Lilly (NYSE: LLY) is in the headlines all the time now, thanks to its latest blockbuster drugs for diabetes and obesity. And with more attention being paid to the company's successes, it's no surprise that hype is building about its future performance as an investment.
As smart investors know, it's a losing strategy to buy a stock right when its slate of opportunities is about to narrow. But it's also easy to miss out on growth by staying on the sidelines. Let's untangle the question of whether or not it's too late to make money buying this stock.
There are a couple of reasons why it might be too late to invest in Eli Lilly, starting with its high valuation.
Source Fool.com
